Literature DB >> 18001212

Dietary phytoestrogens, including isoflavones, lignans, and coumestrol, in nonvitamin, nonmineral supplements commonly consumed by women in Canada.

Lilian U Thompson1, Beatrice A Boucher, Michelle Cotterchio, Nancy Kreiger, Zhen Liu.   

Abstract

Twenty-one nonvitamin, nonmineral dietary supplements commonly consumed by women in Canada were analyzed for isoflavones (formononetin, daidzein, genistein, glycitein), lignans (pinoresinol, lariciresinol, secoisolariciresinol, matairesinol), and coumestrol to complement our previously published food phytoestrogen database. Supplements containing soy or red clover had the highest concentrations of total isoflavones (728.2-35,417.0 ug/g) and total phytoestrogens (1030.1-35,517.7 ug/g) followed by licorice and licorice-containing supplements (41.3-363.3 ug/g isoflavones; 56.5-370.0 ug/g total phytoestrogens). Other supplements had considerably less isoflavones (</= 19.0 ug/g) and total phytoestrogens (</= 44.2 ug/g). Lignans were present in all (</= 298.9 ug/g), whereas coumestrol was either not present or present in only small amounts (</= 3.0 ug/g). Supplements differed in phytoestrogen profiles. The daily intake of isoflavones and lignans from some supplements may greatly exceed those from several servings of soy or vegetables. Hence, the intake of supplements should be taken into consideration in clinical or epidemiological studies for more accurate estimation of phytoestrogen intakes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18001212     DOI: 10.1080/01635580701420616

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

1.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

2.  Improving the estimation of flavonoid intake for study of health outcomes.

Authors:  Julia J Peterson; Johanna T Dwyer; Paul F Jacques; Marjorie L McCullough
Journal:  Nutr Rev       Date:  2015-06-16       Impact factor: 7.110

3.  Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.

Authors:  Joshua D Lambert; Seok-Joo Kwon; Jihyeung Ju; Mousumi Bose; Mao-Jung Lee; Jungil Hong; Xingpei Hao; Chung S Yang
Journal:  Carcinogenesis       Date:  2008-08-05       Impact factor: 4.944

4.  The menstrual cycle and sexual behavior: relationship to eating, exercise, sleep, and health patterns.

Authors:  Susan G Brown; Lynn A Morrison; Marites J Calibuso; Tess M Christiansen
Journal:  Women Health       Date:  2008

Review 5.  Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.

Authors:  Darren R Brenner; Nigel T Brockton; Joanne Kotsopoulos; Michelle Cotterchio; Beatrice A Boucher; Kerry S Courneya; Julia A Knight; Ivo A Olivotto; May Lynn Quan; Christine M Friedenreich
Journal:  Cancer Causes Control       Date:  2016-03-12       Impact factor: 2.506

6.  Postdiagnosis Isoflavone and Lignan Intake in Newly Diagnosed Breast Cancer Patients: Cross-Sectional Survey Shows Considerable Intake from Previously Unassessed High-Lignan Foods.

Authors:  Beatrice A Boucher; Susitha Wanigaratne; Shelley A Harris; Michelle Cotterchio
Journal:  Curr Dev Nutr       Date:  2017-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.